
SNANF
Healthcare · Biotechnology · $24.2M market cap
$0.1966+0.01 (+8.3%)Nov 13, 12:29 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Oct 31, 2025
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jun 26, 2025 | Time not confirmed | — | -0.02 | — |
| Apr 25, 2025 | After the close | — | -0.01 | — |
| Apr 26, 2024 | After the close | — | -0.01 | — |
| Jun 29, 2021 | Before the open | — | -0.03 | — |
| Mar 1, 2021 | After the close | -0.04 | -0.04 | 0.0% |
| Jan 31, 2021 | Time not confirmed | -0.04 | -0.05 | -15.5% |
| Sep 29, 2020 | After the close | — | -0.04 | — |
| Jun 29, 2020 | After the close | — | -0.02 | — |
| Apr 3, 2020 | After the close | — | -0.01 | — |
| Jan 31, 2020 | Time not confirmed | — | -0.00 | — |
| Oct 31, 2019 | Time not confirmed | — | -0.01 | — |
| Jul 31, 2019 | Time not confirmed | — | -0.02 | — |
| Apr 30, 2019 | Time not confirmed | — | -0.01 | — |
Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the…
| Time not confirmed |
| — |
| -0.00 |
| — |
| Oct 31, 2018 | Time not confirmed | — | -0.07 | — |
| Jul 31, 2018 | Time not confirmed | — | -0.01 | — |
| Apr 30, 2018 | Time not confirmed | — | -0.01 | — |
| Jan 31, 2018 | Time not confirmed | — | -0.01 | — |